Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10…
Enveda, a biotechnology company using AI to translate nature into new medicines, announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV with…
Read More...
Read More...